Literature DB >> 15976107

Double-gradient-denaturing-gradient gel electrophoresis for mutation screening of the BCR-ABL tyrosine kinase domain in chronic myeloid leukemia patients.

Nathalie Sorel1, Florence Chazelas, André Brizard, Jean-Claude Chomel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15976107     DOI： 10.1373/clinchem.2004.047274

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  4 in total

Review 1.  Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.

Authors:  Timothy Hughes; Michael Deininger; Andreas Hochhaus; Susan Branford; Jerald Radich; Jaspal Kaeda; Michele Baccarani; Jorge Cortes; Nicholas C P Cross; Brian J Druker; Jean Gabert; David Grimwade; Rüdiger Hehlmann; Suzanne Kamel-Reid; Jeffrey H Lipton; Janina Longtine; Giovanni Martinelli; Giuseppe Saglio; Simona Soverini; Wendy Stock; John M Goldman
Journal:  Blood       Date:  2006-03-07       Impact factor: 22.113

2.  A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib.

Authors:  Thomas Ernst; Franz X Gruber; Oliver Pelz-Ackermann; Jacqueline Maier; Markus Pfirrmann; Martin C Müller; Ingvild Mikkola; Kimmo Porkka; Dietger Niederwieser; Andreas Hochhaus; Thoralf Lange
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

3.  A single-tube allele specific-polymerase chain reaction to detect T315I resistant mutation in chronic myeloid leukemia patients.

Authors:  Wanwisa Wongboonma; Wanna Thongnoppakhun; Chirayu U Auewarakul
Journal:  J Hematol Oncol       Date:  2011-02-08       Impact factor: 17.388

4.  Modeling the influence of stromal microenvironment in the selection of ENU-induced BCR-ABL1 mutants by tyrosine kinase inhibitors.

Authors:  Djamel Aggoune; Lucie Tosca; Nathalie Sorel; Marie-Laure Bonnet; Fatima Dkhissi; Gérard Tachdjian; Annelise Bennaceur-Griscelli; Jean-Claude Chomel; Ali G Turhan
Journal:  Oncoscience       Date:  2014-01-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.